Business Description
Hualan Biological Vaccine Inc
ISIN : CNE1000058J9
Share Class Description:
SZSE:301207: Class ACompare
Compare
Traded in other countries / regions
301207.China IPO Date
2022-02-18Description
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.26 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.51 | |||||
| Interest Coverage | 88.12 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.75 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.8 | |||||
| 3-Year EBITDA Growth Rate | -2.5 | |||||
| 3-Year EPS without NRI Growth Rate | -11.7 | |||||
| 3-Year FCF Growth Rate | 66.1 | |||||
| 3-Year Book Growth Rate | 37.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.68 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.97 | |||||
| 9-Day RSI | 38.91 | |||||
| 14-Day RSI | 44.06 | |||||
| 3-1 Month Momentum % | 28.26 | |||||
| 6-1 Month Momentum % | 10.65 | |||||
| 12-1 Month Momentum % | -28.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.08 | |||||
| Quick Ratio | 2.92 | |||||
| Cash Ratio | 1.25 | |||||
| Days Inventory | 381.65 | |||||
| Days Sales Outstanding | 377.56 | |||||
| Days Payable | 153.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.12 | |||||
| Dividend Payout Ratio | 0.68 | |||||
| Forward Dividend Yield % | 3.12 | |||||
| 5-Year Yield-on-Cost % | 3.12 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 3.2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.67 | |||||
| Operating Margin % | 32.58 | |||||
| Net Margin % | 30.17 | |||||
| FCF Margin % | 42.14 | |||||
| ROE % | 8.13 | |||||
| ROA % | 6.46 | |||||
| ROIC % | 11.32 | |||||
| 3-Year ROIIC % | -4.12 | |||||
| ROC (Joel Greenblatt) % | 23.8 | |||||
| ROCE % | 9.47 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.69 | |||||
| Forward PE Ratio | 11.01 | |||||
| PE Ratio without NRI | 21.13 | |||||
| Price-to-Owner-Earnings | 42.99 | |||||
| PEG Ratio | 1.11 | |||||
| PS Ratio | 6.83 | |||||
| PB Ratio | 1.84 | |||||
| Price-to-Tangible-Book | 1.89 | |||||
| Price-to-Free-Cash-Flow | 16.28 | |||||
| Price-to-Operating-Cash-Flow | 15.09 | |||||
| EV-to-EBIT | 17.08 | |||||
| EV-to-EBITDA | 17.08 | |||||
| EV-to-Revenue | 6.05 | |||||
| EV-to-FCF | 14.35 | |||||
| Price-to-GF-Value | 0.57 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.79 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 3.7 | |||||
| Price-to-Net-Cash | 34.55 | |||||
| Earnings Yield (Greenblatt) % | 5.85 | |||||
| FCF Yield % | 6.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hualan Biological Vaccine Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,649.524 | ||
| EPS (TTM) (Â¥) | 0.824 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 37.25 | ||
| 14-Day RSI | 44.06 | ||
| 14-Day ATR (Â¥) | 0.635855 | ||
| 20-Day SMA (Â¥) | 19.4685 | ||
| 12-1 Month Momentum % | -28.69 | ||
| 52-Week Range (Â¥) | 15.42 - 29.69 | ||
| Shares Outstanding (Mil) | 601.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hualan Biological Vaccine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hualan Biological Vaccine Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hualan Biological Vaccine Inc Frequently Asked Questions
What is Hualan Biological Vaccine Inc(SZSE:301207)'s stock price today?
The current price of SZSE:301207 is ¥19.00. The 52 week high of SZSE:301207 is ¥29.69 and 52 week low is ¥15.42.
When is next earnings date of Hualan Biological Vaccine Inc(SZSE:301207)?
The next earnings date of Hualan Biological Vaccine Inc(SZSE:301207) is .
Does Hualan Biological Vaccine Inc(SZSE:301207) pay dividends? If so, how much?
The Dividend Yield %  of Hualan Biological Vaccine Inc(SZSE:301207) is 3.12% (As of Today), Highest Dividend Payout Ratio of Hualan Biological Vaccine Inc(SZSE:301207) was 0.68. The lowest was 0.17. And the median was 0.21. The  Forward Dividend Yield % of Hualan Biological Vaccine Inc(SZSE:301207) is 3.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers